Dominican Republic free zones export $2.6 billion in medical devices and surgical instruments annually, representing 31% of total free zone exports. Companies including Medtronic, Abbott, and Becton Dickinson have operated there for decades under Law 8-90 (0% corporate income tax) with duty-free U.S. market access via CAFTA-DR. The DR is the largest medical device exporter in the Caribbean Economic Corridor.

DR vs Competing Locations for Medical Device Manufacturing

Want these numbers applied to your specific operation? Get a free analysis

Regulatory Environment

DR free zone medical device manufacturers operate under FDA 21 CFR Part 820 quality system requirements for U.S.-bound devices. ISO 13485 certification is standard across established parks. CNZFE oversight does not conflict with FDA registration requirements — the two regulatory frameworks run in parallel.

Device History Records, supplier qualification documentation, and incoming inspection processes are well-established in DR free zone operations. The 30-year manufacturing history means trained quality engineers, validated processes, and experienced supervisory talent are available in the labor market.

April 2026 Update: Section 232 Tariff Exposure

The Trump administration’s April 2, 2026 Section 232 proclamation imposes a 100% tariff on patented pharmaceutical imports effective July 31, 2026. Medical devices are under active Section 232 investigation. Goods produced in DR free zones and exported under CAFTA-DR are not subject to these tariffs. For medical device companies currently producing in China, India, or other non-exempt markets, this creates direct cost exposure that DR free zone production avoids.

Frequently Asked Questions

Which device classes are manufactured in DR free zones? Class I and Class II devices dominate DR production. Class III is present but less common. Surgical instruments, disposables, diagnostics, and implantable components are all manufactured in established DR parks.

Are FDA inspections conducted in DR facilities? Yes. DR free zone facilities producing U.S.-bound medical devices are subject to FDA inspection under standard foreign establishment registration requirements. Established operators have maintained compliance records over multiple inspection cycles.

Does the CAFTA-DR rules of origin requirement affect medical devices? Rules of origin for medical devices under CAFTA-DR require that goods undergo sufficient transformation in the DR. For most device categories involving assembly, packaging, and sterilization, the rules of origin are achievable. Category-specific analysis is recommended.

Explore More: EGS Insights Hub | DR Manufacturing Sectors | Contact Our Team